DigitalHealth 1400x300

LSE Health Digital

Regulation, Economics, Policy, Data Management

Digital health generally refers to the use of internet solutions, big data, and communications technologies to collect, share and manage health information to improve both individual and public health, as well as identify symptoms, plan treatment, monitor key health parameters, and monitor progress and treatment effects. One aspect of digital health, namely telemedicine has grown rapidly throughout the COVID-19 pandemic. Many of the efforts in this field were designed to help mitigate the effects of the pandemic and to ensure that healthcare delivery could continue as much as possible. With the rise in the development and use of digital health products, there is a need to understand their impact on healthcare. However, evidence supporting comparative effectiveness and cost-effectiveness of these products is limited. Regulatory policy on the adoption of digital health products is lacking and there is an absence of clear guidelines to evaluate their health and economic benefits in clinical practice for policy makers and developers. Similarly, policy environments remain unclear as to how digital health products are classified: do the policies for medical technologies also cover digital health or is digital health yet another archetype? Additionally, there are important considerations with regards to the impact of digital health on health inequalities due to digital exclusion. How can digital health tools be utilised in a way that it contributes to the improvement of health outcomes instead of widening existing divides?

LSE Health Digital focuses on providing clarity on these types of questions. We are a team of experts from the public and private sector, as well as academia. Our shared experience ranges from policy analyses and advising to health technology assessment and economic evaluations to exploring, understanding, and addressing health inequalities. 

What do we do

In more specific terms, LSE Health Digital has four areas of interest:

  • Governance of digital health

  • Policy and regulatory options surrounding digital health

  • Economic evaluations and reimbursement processes of digital health tools and therapeutics

  • Digital health and health inequalities


Public Engagement

  • Dr Robin van Kessel participated in the panel "Transforming digital health practice: The critical role of governance, investment and evaluation" at the Second WHO Symposium on the Future of Health Systems in a Digital Era in the European Region (5-6 Sept 2023). You can watch his talk here.

  • Dr Divya Srivastava gave the talk AI in Healthcare, assessing how AI is being deployed in healthcare.



Who is involved

Robin Van Kessel_200px

Dr Robin Van Kessel
Health Policy Research Associate



Ilias 200x200

Dr Ilias Kyriopoulos
Assistant Professor of Health Policy

COW 3.03 


HarpreetSood 200x200

Dr Harpreet Sood
Health Education England


UrrestarazuRoman 200x200

Dr Andres Roman-Urrestarazu
Department of Psychiatry, University of Cambridge


Giovani Monti

Giovanni Monti
Visiting Senior Fellow


George Wharton

George Wharton
Senior Lecturer, Department of Health Policy

COW 2.14
+44 (0)20 7107 5488


Elias Mossialos 200x200

Professor Elias Mossialos
Brian Abel-Smith Professor of Health Policy; Director, LSE Health; Co-Director, European Observatory on Health Systems and Policies

+44 (0)20 7955 7564


For more information, please contact Dr Robin van Kessel at



Check back later for our latest Twitter updates.

Contact us


LSE Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE

Follow us